Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak

During the coronavirus disease 2019 (COVID-19) pandemic, immunomodulatory therapies and hospital admission were suspected to increase the risk of infection. Nevertheless, patients with inflammatory bowel diseases (IBD) treated with intravenous (i.v.) biologics had to move to hospitals for drug infus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertani, Lorenzo, Barberio, Brigida, Tricò, Domenico, Zanzi, Federico, Maniero, Daria, Ceccarelli, Linda, Marsilio, Ilaria, Coppini, Francesca, Lorenzon, Greta, Mumolo, Maria Gloria, Zingone, Fabiana, Costa, Francesco, Savarino, Edoardo Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348517/
https://www.ncbi.nlm.nih.gov/pubmed/34362053
http://dx.doi.org/10.3390/jcm10153270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348517/
https://www.ncbi.nlm.nih.gov/pubmed/34362053
http://dx.doi.org/10.3390/jcm10153270

Ejemplares similares